Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. (Q37038412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

0 references

splenic marginal zone lymphoma

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Miguel A. Piris

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Oscier D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Montalban C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Berger F

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Callet-Bauchu E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dogan A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Felman P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Franco V

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Iannitto E

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mollejo M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Papadaki T

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Remstein ED

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Solé F

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Stamatopoulos K

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Thieblemont C

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Traverse-Glehen A

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Wotherspoon A

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Coiffier B

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Matutes E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

20 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

487-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2405068

30 December 2019

exact match

0 references

cites work

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic marginal-zone lymphoma: a distinct clinical and pathological entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic marginal zone lymphoma: a prognostic model for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic marginal zone lymphomas appear to originate from different B cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d'Hématologie Cellulaire (GFHC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Marginal zone B-cell lymphoma in children and young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Nodal and splenic marginal zone B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

The natural history and clinico-pathological features of the variant form of hairy cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Rituximab monotherapy is highly effective in splenic marginal zone lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic Marginal-zone Lymphoma: One or More Entities? A Histologic, Immunohistochemical, and Molecular Study of 42 Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Lymph Node Involvement by Splenic Marginal Zone Lymphoma: Morphological and Immunohistochemical Features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

Splenic marginal zone cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hématologie Cellulaire (GFHC)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. Groupe Français d'Hématologie Cellulaire

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

A Clinicopathological Study of 13 Cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Malignant lymphoma obscured by concomitant extensive epithelioid granulomas: report of three cases with similar clinicopathologic features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Splenic marginal zone lymphoma with or without plasmacytic differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

VH gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Cytogenetic studies in splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

p53 abnormalities in splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405068

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2405068

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference